Notice for nelarabine (Reach Pharmaceuticals Pty Ltd)
Active ingredients
nelarabine
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for infusion
Indication
Treatment of patients with t-cell acute lymphoblastic leukemia and t-cell lymphoblastic lymphoma
Therapeutic area
Haematology